Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
69 Cards in this Set
- Front
- Back
- 3rd side (hint)
Abnormal, uncontrolled proliferation and accumulation of one or more hematopoietic cells |
Leukemia |
|
|
Leukemia that is rapidly progressive Lasts for several days to 6 Mos |
Acute Leukemia |
|
|
Duration of Subacute Leukemia |
2-6 Mos |
|
|
Variable Duration, depending on the age of the px and type of cell involved Most pxs lived a minimum of 1-2 Years or more |
Chronic Leukemia |
|
|
WBC Count >15,000/uL |
Leukemic Leukemia |
|
|
WBC Count <15,000/uL With Immature or Abnormal forms of WBCs in peripheral blood |
Subleukemic Leukemia |
|
|
WBC Count of <15,000/uL With No Immature or Abnormal WBCs in peripheral blood |
Aleukemic Leukemia |
|
|
Leukemia w/ predominance of immature cell types (blasts & pro stages) |
Acute Leukemia |
Abrupt Onset of Symptoms |
|
Leukemia w/ predominance of Mature Cells |
Chronic Leukemia |
Gradual Onset of Symptoms |
|
FAB Criteria for Leukemia Include: |
1. Morphology 2. Cytochemistry 3. Immunophenotyping |
|
|
WHO Criteria for Leukemia |
1. Morphology 2. Cytochemistry 3. Immunophenotyping 4. Cytogenetics 5. Clinical Features |
|
|
FAB Diagnostic Criteria of AML |
>/= 30% Blasts |
|
|
WHO Diagnostic Criteria for AML |
>/= 20% Blasts |
*Widely Used Criteria |
|
Acute Lymphoblastic Leukemia type in which Lymphoblasts are small & homogenous
Most common type of Childhood ALL
Best prognosis |
L1 |
Cytoplasm: Scanty Nuclei: Inconspicuous Nucleus: Round & Irregular *Lymphoblasts have a very high N/C Ratio |
|
ALL Type in which Lymphoblasts are larger and variable in size (Large Heterogenous) Adult Type ALL |
L2 |
Cytoplasm: Abundant, Basophilic Nuclei: Clefted, W/ nucleoli
|
|
ALL Type in which Lymphoblasts are Large but varies little in size (Large Homogenous) Burkitt Type
Rarest
Prognosis is Poor |
L3 |
W/ Prominent Vacuoles Cytoplasm: Moderate in quantity, deeply basophilic Nucleus: Round w/ fine chromatin structure, 1-3 nucleoli |
|
M7 |
Acute Megakaryocytic Leukemia |
1. Large & Small Megakaryoblasts 2. High N/C Ratio 3. Pale Agranular Cytoplasm |
|
Acute Myelomonocytic Leukemia |
M4 |
1. Both Myeloid & Monocytic Cells are present (20% of Total Leukocytes) |
|
M0 |
Acute Myeloid Leukemia, minimally differentiated |
Undiffetentiated Blasts |
|
Acute Monocytic Leukemia, poorly differentiated (w/out maturation) |
M5a |
|
|
M2 |
Acute Myeloid Leukemia w/ Maturation |
Myeloid cells demonstrate maturation beyond blast and promyelocyte stage |
|
M6 |
Acute Erythroleukemia
Erythremic Myelosis Di Guglielmo's Syndrome |
1. Abnormal prolif of both erythroid & granulocytic precursors 2. May also include abnormal megakaryocytic, and monocytic prolif |
|
Acute Monocytic Leukemia Well differentiated (w/ maturation) |
M5B |
>80% Monocytic Cells |
|
M1 |
Acute Myeloid Leukemia w/out Maturation |
|
|
Acute Promyelocytic Leukemia |
M3 |
1. Translocation in 15 & 17 2. DIC may occur 3. Presence of Faggot Cells w/mass of Auer Rods |
|
Myelodysplastic Syndrome in which there is 1. <1% of blasts in the Peripheral Blood 2. <5% of blasts in BM 3. May or may have ringed sideroblasts |
Refractory Anemia or Refractory Cytopenia (RA/RC) |
|
|
Myelodysplastic Syndrome in which there is 1. <1 % of blasts in Peripheral Bld 2. <5% of blasts in BM 3. >15% RINGED SIDEROBLAST |
Refractory Anemia w/ Ringed Sideroblasts (RARS) |
|
|
Myelodysplastic Syndrome in which there is 1. <5% of Blasts in Peripheral Bld 2. 5-20% of blasts in BM 3. May or may have Ringed Sideroblast |
Refractory Anemia w/ Excess Blasts (RAEB) |
|
|
Myelodysplastic Syndrome in which there is 1. >5% of Blasts in Peripheral Bld 2. 20-30% Blasts in BM 3. May or may have Ringed Sideroblast |
Refractory Anemia w/ Excess Blasts in Transformation (RAEBIT) |
|
|
Myelodysplastic Syndrome in which there is 1. <5% Blasts in peripheral bld 2. 5-20% Blasts in BM 3. No ringed sideroblast |
Chronic Myelomonocytic Leukemia (CMML) |
|
|
Clonal Abnormality in Hematopoietic tissues Pre-leukemia that can progess to ALL |
Myelodysplastic Syndrome (MDS)/ Dysmyelopoietic Syndrome |
|
|
Majority of cases appear to involve B Lymphocytes (Fragile than normal) Large number of Smudge Cells More than twice as common in men than in women |
Chronic Lymphocytic Leumemia (CLL) |
A Lymphoproliferative Disorder |
|
Group of malignant tumors of lymphoid tissue (lymph nodes & spleen) |
Lymphoma |
Types: 1. Non-Hodgkin's 2. Hodgkin's 3. Burkitt's 4. Sezary Syndrome |
|
Proliferations of malignant lymphocytes (primarily B cells) that are arrested at certain ages of maturation Classified by Rappaport System |
Non-Hodgkin's Lymphoma |
Frequent in middle & older age |
|
Presence of Reed-Sternberg Cells (Large Cell w/ large nucleoli) The cells reacting to neoplasm is predominant rather than the neoplastic cells |
Hodgkin's Disease/Lymphoma |
Frequent in young & middle aged
Classified According to: 1. Rye Classification - Histolologic Apperance of Lymphoid Tissue 2. Ann Arbor Classification - Most widely used staging -Histoligic type & extent of tissue involvement |
|
Found most often in children of Africa & New Guinea commonly affects jaw & facial bones EBV isolated from tumor cells plays a role in transforming the B lymphocytes by binding to surface receptors |
Burkitt's Lymphoma |
|
|
Leukemic Phase of Mycosis Fungoides affecting predominantly older males Malignant lymphoma, affecting the skin, involves primarily T lymphocytes |
Sezary Syndrome |
T Lymphocytes (+) monoclonal abs for CD2, 3, 4 |
|
Resemble a medium-sized lymphocyte w/ convoluted ceribriform (brain-like) nucleus, resembling monocyte nucleus |
Sezary Cells |
|
|
(+) Acid Phosphatase Stain using L Tartaric Acid Cells are resistant to Inhibition by Tartaric Acid Characteristic B lymphocytes |
Hairy Cell Leukemia |
Leukemic Reticuloendotheliosis |
|
Group of acquired malignant disorders that develop from the proliferation of an abnormal pluripotential stem cell |
Myeloproliferative Disorders |
|
|
Stem cell disorder affecting the granulocytic, monocytic, erythrocytic, megakaryocytic cell lines One arm of Chromosome 22 is translocated to Chromosome 9 (Philadelphia Chromosome) |
Chronic Myelogenous Leukemia/Chronic Granulocytic Leukemia |
|
|
Indication of (-) Philadelphia Chromosome |
1. Poorer Prognosis 2. Do not respond Well to therapy |
|
|
Difference b/w CML & Leukemoid Reaction |
CML: 1. High WBC Count 2. Shift to the left w/ blasts, eosinophilia, & basophilia 3. LOW LAP 4. (+) Philadelphia Chromosome |
Leukemoid Reaction: 1. High WBC 2. Shift to the left (blasts rare), toxic granulation, dohle bodies 3. HIGH LAP 4. (-) Philadelphia Chromosome |
|
Fibrosis and granulocytic hyperplasia of the BM, w/ granulocytic and megakaryocytic proliferation in the liver & spleen |
Myelofibrosis w/ Myeloid Metaplasia |
|
|
Chronic MPD w/ thrombocytosis in excess of 1000 x 10^9/L w/ spontaneous aggregation of functionally abnormal platelets |
Essential Thrombocythemia |
|
|
Characterized by an Inc in RBC, WBC, PLTS |
Polycythemia Vera |
Panhyperplasia BM: Panmyelosis BLD: Pancytosis Dec EPO, Inc HCT |
|
Above normal Hgb, RBC, Hct >50% |
Polycythemia/Erythrocytosis |
|
|
Chronic Myeloproliferative Dse Inc RBCs, WBCs, Plts D/t Increased RBC Conc, Inc Blood viscosity the px exhibits Ruddy Skin Coloration Dec EPO |
Primary Absolute Polycythemia/ Polycythemia Vera |
|
|
Appropriate response to Hypoxia
Caused by: 1. Residence @ high altitude 2. Pulmonary & Cardiac Dse
Inc RBCs, WBCs, Plts |
Secondary Polycythemia w/ appropriate pxn of EPO |
Secondary Polycythemia w/ Inappropriate Pxn of EPO - Seen in certain tumors - Normal RBCs, WBCs, Plts |
|
Caused by a dec in the fluid (plasma) portion of the blood
Actual # of RBC not Inc, but the # of cells per unit volume is Inc
Acute Dehy, Stress, Anxiety |
Relative Polycythemia |
Spurious Polycythemia - Gaisbock's Syndrome - Occurs primarily in middle-aged males & may be associated w/ smoking, cardiovascular problems, hypertension & diuretic therapy |
|
Marker for primary granules and Auer rods
Deteriorates, should be done only on fresh specimens
Dark Brown Granules in cytoplasm of granulocytes and monocytes |
Myeloperoxidase (MPO) |
(+) AML (-) ALL |
|
Marker for phospholipids & lipids Can be done on stored specimens Dark Purple Granules in neutrophil precursors Lymphoblasts (-) |
Sudan Black B (SBB) |
(+) AML (-) ALL |
|
Marker for immature lymphocytes DNA Polymerase, Immunoperoxidase Present in 90% of ALL Differentiate ALL from AML |
Terminal Deoxyribonucleotidyl Transferase (TdT) |
(+) ALL (-) AML |
|
Marker for glycogen, glycoproteins mucoproteins, & high molecular weight carbohydrates
Activity results in Bright Fuchsia Pink |
Periodic Acid-Schiff |
Normally All Blood Cells are (+) exc: Erythrocytes
L1 & L2: BLOCK or Chunky PATTERN L3: NEGATIVE Erythroblasts in M6 Leukemia: POSITIVE |
|
Marker for mature & immature neutrophils & mast cells Bright Red Granules in Cytoplasm Specific Esterase Stable Enzyme, lasts for months |
Naphthol AS-D Chloroacetate Esterase |
Differentiates Granulo (+) from Mono (-) |
|
Marker for monocytes, megakaryocytes, & plasma cells Monocytes are Red-brown Non-specific Esterase |
A-Naphthyl Acetate Esterase |
|
|
For id of monocytes, promonocytes, monoblasts Dark Red precipitates in cytoplasm Non-specific Esterase |
A-Naphthyl Butyrate Esterase |
Specific = Mono (+) Granulo(-) |
|
Present in all hematopoietic cells & lysosomes Purple to Red Granules Can't be stored |
Acid Phosphatase |
(+) Hairy Cell Leukemia using L (+) Tartaric Acid (+) Trap (-) Non T Cell Leukocytes |
|
Excellent marker for Hairy Cell Leukemia Purple to Dark Red granules in cytoplasm |
Tartrate Resistant Acid Phosphatase |
|
|
Only Neutrophils contains this activity, stains its ALP Used to differentiate CML (Low) w/ Leukemoid Reaction (High) |
Leukocyte Alkaline Phosphatase |
Specimen: 1. Fresh Capillary Bld (Heparin) EDTA = Falsely Low
100 Cell Count Scoring: 0 no activity 4 w/ large amount of activity |
|
Binds w/ acid mucopolysaccharides in blood cells Useful for recognition of mast cells & tissue basophils Strongly Metachromatic |
Toluidine Blue |
|
|
Color Reactions: 1. MPO 2. Sudan Black B 3. PAS 4. Naphthol AS-D Chloroacetate Esterase 5. A-Naphthyl Acetate Esterase 6. A-Naphthyl Butyrate Esterase 7. ACP 8. Tartrate Resistant ACP |
1. MPO - Dark Brown 2. Sudan Black B - Dark Purple 3. PAS - Bright Fuschia Pink 4. Naphthol AS-D Chloroacetate Esterase - Bright Red 5. A-Naphthyl Acetate Esterase - Red Brown 6. A-Naphthyl Butyrate Esterase -Dark Red 7. ACP -Purple to Red 8. Tartrate Resistant ACP -Dark Purple to Red |
|
|
Most common type of microscope used in Hema Examine Blood Films |
Brightfield Microscopy |
|
|
Ensures an optimum contrast and resolution for the maximum definition of the specimen details by precisely focusing and centering light path and spreading the light uniformly over the field view |
KOEHLER/KOHLER ILLUMINATION |
|
|
Type of Brightfield Microscopy that gives a 3D Image |
Interfernce Contrast Microscope |
Hoffman: MODULATION CONTRAST
Nomarski: DIFF INTERFERENCE CONTRAST |
|
Microscope used for ANA & T & B-Cell studies |
Fluorescence Microscopy |
|
|
Used for observation of fine ultrastructure of cells w/ magnification of approx. X100, 000 |
Electron Microscopy |
|
|
Used for Manual Platelet Counts |
Phase-Contrast Microscopy |
Halo |
|
Used for observation of erythrocyte morphology, & differentiates leukocytes |
Oil Immersion Microscopy |
Solution for Cleaning: 1. Lens Cleaner 2. Alcohol |